Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, has settled all outstanding disputes with Retrophin Inc., the biopharmaceutical company he founded in 2011 and which ousted him three years later.
The settlement also covers claims Retrophin first raised in August 2015, in a $65 million lawsuit accusing Shkreli of repeatedly breaching his duty of loyalty to the San Diego-based company. That case moved to arbitration last year.“Retrophin and Martin Shkreli have reached a settlement resolving all outstanding disputes between them,” the spokeswoman said. “We are pleased with this outcome.”
globebusiness Chunky monkey !
globebusiness Money buys Innocence!!! This guy is a genius, but a horrible human. HORRIBLE!! His own Lawyer talked Sh$t about him but, was getting paid well, so Meh.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: globeandmail - 🏆 5. / 92 Weiterlesen »